Similarly, in two lines of primary colon cancer cells (patient-derived), icaritin (10 μM) treatment induced Beclin-1, ATG-5 and LC3B-II upregulation but p62 degradation (Figure 1C). The gene discussed is BECN1; the disease is colonic neoplasm.